RecruitingNot ApplicableNCT06903845

APIXABAN App Study

The Effect of App. for Medication-check and Video-call Guided Education on APIXABAN Adherence in Patients of Atrial Fibrillation With Cardiac Disease: Randomised Control Pilot Study(APIXABAN Study)

Sponsor

Dong-Ju Choi

Enrollment

40 participants

Start Date

Mar 1, 2025

Study Type

INTERVENTIONAL

Conditions

Atrial Fibrillation

Summary

The aim of this clinical trial is to evaluate whether the medication reminder app and video call can improve medication adherence to apixaban in patients with AF and comorbidities. Patients with AF and comorbid heart disease taking apixaban who meet the inclusion criteria will be randomised 1:1 to a treatment arm using a medication reminder app and bi-weekly video education and a control arm using the medication reminder app alone to compare medication adherence. Patients in both groups will use the medication app, but only the treatment group will receive additional education and feedback via video call every two weeks to reinforce the use of the medication app and medication reminders with video education. The study aims to assess the change in adherence between the two groups at week 8.

Eligibility

Min Age: 19 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether a smartphone app can help people with an irregular heartbeat (atrial fibrillation) stick to their blood-thinning medication (apixaban) and manage their condition better. **You may be eligible if...** - You are 19 years old or older - You have been diagnosed with atrial fibrillation (an irregular heartbeat) - You also have at least one of: heart failure, high blood pressure, coronary artery disease, peripheral artery disease, diabetes, a prior stroke, or another heart condition requiring treatment - You are currently taking or about to start apixaban - You own an Android smartphone **You may NOT be eligible if...** - Your kidneys are functioning poorly (creatinine clearance below 15 mL/min) - You have moderate to severe mitral valve narrowing - You have had a mitral valve repair or replacement - You have a significant history of alcohol or substance abuse - You are currently in another drug trial Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.